IL-11 has recently been recognized as a TGF-β-responsive profibrotic cytokine and was shown to be highly upregulated in dermal fibroblasts from SSc skin and in pulmonary fibroblasts from patients suffering from interstitial lung disease associated with SSc [36, 37]. This evidence concerns the gene IL11 and systemic sclerosis.